ESC 365 - Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation

EHRA Premium Access

Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation

Session: Atrial fibrillation: heart failure

Topic: Mechanisms for Heart Failure and Cardiac Complications

Speaker: Ms R. Arnet (Basel, CH)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Ms Rebecca Arnet

Cardiovascular Research Institute Basel, Basel (Switzerland)

0 follower

7 more presentations in this session

Single center experience of efficacy and safety of atrioventricular node ablation after left bundle branch area pacing for the management of atrial fibrillation

Speaker: Doctor M. Jacobs (Tours, FR)

Improvement in atrial functional and ventricular functional tricuspid regurgitation following catheter ablation or cardioversion of atrial fibrillation

Speaker: Doctor B. Kuru Gorgulu (Istanbul, TR)

Stroke after implantable cardioverter-defibrillator shocks in patients with heart failure

Speaker: Mr M. Dyrbus (Zabrze, PL)

Newly diagnosed heart failure in patients with atrial fibrillation referred for catheter ablation - identifying patients with arrhythmia-induced cardiomyopathy

Speaker: Doctor J. Riess (Davos Wolfgang, CH)

Definition and management of arrhythmia-induced cardiomyopathy: findings from the EHRA SIC survey

Speaker: Associate Professor P. Badertscher (Basel, CH)

Access the full session

Atrial fibrillation: heart failure

Speakers: Ms R. Arnet, Doctor M. Jacobs, Doctor B. Kuru Gorgulu, Mr M. Dyrbus, Doctor J. Riess...

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources